Monthly Archives :

May 2021

  • No Comments
Metabolic profile of tumor skin cells after low-levellaser therapy
Metabolic profile of tumor skin cells after low-levellaser therapy 1125 1625 Metabolism & Cancer
42- Tatiane Veloso, Universidade do Estado do Rio de Janeiro, Brazil read more
  • No Comments
Targeting the metabolic reprogramming associated with cdk4/6 inhibition as an effective combined therapy in colon cancer
Targeting the metabolic reprogramming associated with cdk4/6 inhibition as an effective combined therapy in colon cancer 1241 1755 Metabolism & Cancer
63- Míriam Tarrado-Castellarnau, Instituto de Salud Carlos III (ISCIII), Barcelona, Spain read more
  • No Comments
Characterization by Mass Spectrometry of the lipid metabolism in the different molecular breast cancer subtypes
Characterization by Mass Spectrometry of the lipid metabolism in the different molecular breast cancer subtypes 1125 1625 Metabolism & Cancer
24- Jose Adriá, FUNCA, IISPV, Reus, Spain read more
  • No Comments
Serine metabolism controls lung adenocarcinoma cells migratory ability by modulating AMP kinase activity
Serine metabolism controls lung adenocarcinoma cells migratory ability by modulating AMP kinase activity 1755 1241 Metabolism & Cancer
60- Amani Bouzidi, Sapienza University, Rome, Italy read more
  • No Comments
Exploring serum metabolomics by advanced 1H-NMR profiling in breast cancer patients
Exploring serum metabolomics by advanced 1H-NMR profiling in breast cancer patients 1125 1625 Metabolism & Cancer
29- Ylenia Ávivar, URLA, URV, Reus, Spain read more
  • No Comments
Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable for MCT4 inhibition
Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable for MCT4 inhibition 1125 1625 Metabolism & Cancer
65- Catherine Vander Linden, UCLouvain, Brussels, Belgium read more
  • No Comments
Metabolic Vulnerabilities as Predictive Biomarkers and Therapeutic Targets in Skin Carcinogenesis
Metabolic Vulnerabilities as Predictive Biomarkers and Therapeutic Targets in Skin Carcinogenesis 1811 2560 Metabolism & Cancer
43- Pauline Michon, U1035, INSERM, Bordeaux, France read more
  • No Comments
Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape
Methylglyoxal, a byproduct of glycolysis, modulates breast cancer immune landscape 1707 2560 Metabolism & Cancer
44- Tom Wissocq, GIGA-Cancer, Univeristy of Liège, Belgium read more
  • No Comments
Metabolic plasticity in metastatic colorectal cancer in response to Palbociclib
Metabolic plasticity in metastatic colorectal cancer in response to Palbociclib 1241 1755 Metabolism & Cancer
41- Claudia Hernández-Carro, University of Barcelona, Spain read more
Enter your
text here